Similar articles for PMID: 40037862

Year	Number of Results
2014	3
2015	1
2018	1
2019	1
2020	2
2021	5
2022	2
2023	5
2024	57
2025	55

1

Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence After Preoperative Chemotherapy and Surgery for Gastric Cancer.

Komori K, Yamada T, Ando S, Nagasawa S, Kanematsu K, Morita J, Tanabe M, Nakayama Y, Rino Y, Saito A, Ogata T, Oshima T. Komori K, et al. Anticancer Res. 2025 Mar;45(3):1205-1214. doi: 10.21873/anticanres.17507. Anticancer Res. 2025. PMID: 40037862

2

Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.

Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B, van Grieken NCT, Nilsson M, Collienne M, Giraut A, Smyth E. Lordick F, et al. Ann Oncol. 2025 Feb;36(2):197-207. doi: 10.1016/j.annonc.2024.10.829. Epub 2024 Nov 13. Ann Oncol. 2025. PMID: 39542422 Free article. Clinical Trial.

3

Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.

Bryant A, Hiu S, Kunonga PT, Gajjar K, Craig D, Vale L, Winter-Roach BA, Elattar A, Naik R. Bryant A, et al. Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.

4

Prognostic factors and significance of postoperative adjuvant chemotherapy in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy followed by gastrectomy.

Motoori M, Kishi K, Yamamoto K, Takeno A, Hara H, Murakami K, Hamakawa T, Nakahara Y, Masuzawa T, Omori T, Kurokawa Y, Fujitani K, Doki Y. Motoori M, et al. Surg Today. 2024 Nov;54(11):1379-1387. doi: 10.1007/s00595-024-02853-7. Epub 2024 Apr 28. Surg Today. 2024. PMID: 38678493

5

[Risk factors and nomogram construction for predicting long-term survival in hepatoid adenocarcinoma of the stomach].

Lu YY, Cui H, Cao B, Xu QX, Gao JW, Zhao RY, Ren HG, Yuan Z, Du JJ, Sun JH, Cui JX, Wei B. Lu YY, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2025 Feb 25;28(2):157-168. doi: 10.3760/cma.j.cn441530-20240910-00312. Zhonghua Wei Chang Wai Ke Za Zhi. 2025. PMID: 39971567 Chinese.

6

[Analysis of prognostic risk factors for patients with locally advanced gastric cancer in the stage ypT0~2N0M0 after neoadjuvant chemotherapy].

Shao XX, Li WK, Hu HT, Lu YM, Tian YT. Shao XX, et al. Zhonghua Zhong Liu Za Zhi. 2024 Dec 23;46(12):1187-1194. doi: 10.3760/cma.j.cn112152-20231024-00217. Zhonghua Zhong Liu Za Zhi. 2024. PMID: 39690543 Chinese.

7

Impact of chemotherapy delay on long-term prognosis of laparoscopic radical surgery for locally advanced gastric cancer: a pooled analysis of four randomized controlled trials.

Zhong Q, Liu ZY, Shang-Guan ZX, Li YF, Li Y, Wu J, Huang Q, Li P, Xie JW, Chen QY, Huang CM, Zheng CH. Zhong Q, et al. Gastric Cancer. 2024 Sep;27(5):1100-1113. doi: 10.1007/s10120-024-01513-6. Epub 2024 May 29. Gastric Cancer. 2024. PMID: 38809487

8

Downstaging Effect Rather than the Full Intended Cycles of Perioperative Chemotherapy Determines the Value of Adjuvant Chemotherapy in Gastric Cancer.

Li Z, Sun C, Fei H, Li Z, Zhao D, Guo C, Du C. Li Z, et al. Ann Surg Oncol. 2025 Jan;32(1):342-350. doi: 10.1245/s10434-024-16365-8. Epub 2024 Oct 24. Ann Surg Oncol. 2025. PMID: 39448412

9

Prognostic factors and adjuvant chemotherapy efficacy in stage I gastric cancer patients: a retrospective analysis.

Xiao H, Li H, Jian L, Ai Z, Hu P. Xiao H, et al. BMC Gastroenterol. 2024 Dec 24;24(1):474. doi: 10.1186/s12876-024-03573-5. BMC Gastroenterol. 2024. PMID: 39719607 Free PMC article.

10

Effectiveness of neoadjuvant chemotherapy with a docetaxel, cisplatin, and S-1 (DCS) regimen for T4b gastric cancer.

Long VD, Thong DQ, Dat TQ, Nguyen DT, Phuoc TD, Hai NV, Vuong NL, Trung LQ, Bac NH. Long VD, et al. World J Surg Oncol. 2024 Dec 20;22(1):335. doi: 10.1186/s12957-024-03620-1. World J Surg Oncol. 2024. PMID: 39707403 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 40037862

101 results

Results by year